Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
1.200
+0.130 (12.15%)
At close: Dec 5, 2025, 4:00 PM EST
1.150
-0.050 (-4.16%)
After-hours: Dec 5, 2025, 7:16 PM EST
Scinai Immunotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 5.14 | 4.8 | -6.5 | -5.8 | -8.21 | -1.39 | |
| Depreciation & Amortization | 1.7 | 1.65 | 0.51 | 0.56 | 0.47 | 0.76 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.05 | |
| Asset Writedown & Restructuring Costs | - | - | - | 0.21 | - | - | |
| Stock-Based Compensation | 0.62 | 0.68 | 1.14 | 1.6 | 2.76 | 2.95 | |
| Other Operating Activities | -13.9 | -13.57 | -3.74 | -4.11 | -3.15 | -20.3 | |
| Change in Accounts Receivable | 0.07 | 0.14 | -0.29 | 0.14 | 0.06 | -0.17 | |
| Change in Accounts Payable | 0 | -0.16 | -0.15 | -0.18 | 0 | -4.73 | |
| Change in Other Net Operating Assets | 0.67 | 0.13 | -0.36 | 0.31 | 0.64 | 0.37 | |
| Operating Cash Flow | -5.69 | -6.34 | -9.38 | -7.27 | -7.43 | -22.56 | |
| Capital Expenditures | -0.02 | -0.01 | -0.64 | -0.84 | -0.14 | -1.91 | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.05 | |
| Other Investing Activities | - | - | - | - | - | 0.01 | |
| Investing Cash Flow | -0.02 | -0.01 | -0.64 | -0.84 | -0.14 | -1.85 | |
| Long-Term Debt Repaid | - | - | - | - | - | -0.39 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.39 | |
| Issuance of Common Stock | 1.59 | 1.44 | 1.09 | 6.78 | 21.43 | 4.65 | |
| Other Financing Activities | 2 | 2 | - | - | - | - | |
| Financing Cash Flow | 3.59 | 3.44 | 1.09 | 6.78 | 21.43 | 4.27 | |
| Foreign Exchange Rate Adjustments | 0.15 | -0.01 | -0.27 | -1.98 | 0.58 | 0.53 | |
| Net Cash Flow | -2.08 | -2.92 | -9.21 | -3.3 | 14.44 | -19.61 | |
| Free Cash Flow | -5.71 | -6.35 | -10.02 | -8.1 | -7.57 | -24.47 | |
| Free Cash Flow Margin | -497.38% | -964.59% | - | - | - | - | |
| Free Cash Flow Per Share | -4.33 | -7.87 | -25.65 | -42.97 | -53.60 | -220.83 | |
| Cash Interest Paid | - | 0.14 | 0.83 | 0.92 | - | 0.01 | |
| Levered Free Cash Flow | -3.39 | -3.82 | -8.28 | -5.52 | -2.71 | -1.88 | |
| Unlevered Free Cash Flow | -2.6 | -2.93 | -5.9 | -5.52 | -2.71 | -1.66 | |
| Change in Working Capital | 0.75 | 0.11 | -0.8 | 0.27 | 0.7 | -4.53 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.